| Literature DB >> 35693782 |
Shaoqing Zang1, Li-Xia Lv1, Chen-Fei Liu1, Peng Zhang1, Cang Li1, Jin-Xing Wang1,2.
Abstract
Trained immunity is driven by metabolism and epigenetics in innate immune cells in mammals. The phenomenon of trained immunity has been identified in invertebrates, including shrimp, but the underlying mechanisms remain unclear. To elucidate mechanisms of trained immunity in shrimp, the metabolomic changes in hemolymph of Marsupenaeus japonicus trained by the UV-inactivated white spot syndrome virus (UV-WSSV) were analyzed using tandem gas chromatography-mass/mass spectrometry. The metabolomic profiles of shrimp trained with UV-WSSV followed WSSV infection showed significant differences comparison with the control groups, PBS injection followed WSSV infection. 16 differential metabolites in total of 154 metabolites were identified, including D-fructose-6-phosphate, D-glucose-6-phosphate, and D-fructose-6-phosphate, and metabolic pathways, glycolysis, pentose phosphate pathway, and AMPK signaling pathway were enriched in the UV-WSSV trained groups. Further study found that histone monomethylation and trimethylation at H3K4 (H3K4me1 and H3K4me3) were involved in the trained immunity. Our data suggest that the UV-WSSV induced trained immunity leads to metabolism reprogramming in the shrimp and provide insights for WSSV control in shrimp aquaculture.Entities:
Keywords: GC–MS/MS; WSSV; metabolites; shrimp; trained immunity
Mesh:
Substances:
Year: 2022 PMID: 35693782 PMCID: PMC9178177 DOI: 10.3389/fimmu.2022.885782
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 8.786
Figure 1Trained immunity model. (A) UV-WSSV-induced trained immunity in M. japonicus. UV-WSSV (50 μL, 5 × 105 copies) was injected into shrimp; the same volume of PBS was injected into controls. Five days after the first injection (training), a second injection of WSSV was administered (50 μL, 5 × 105 copies). Hemolymph was collected at 48 h after the first injection (CP, PBS-injected shrimp; EU, UV-WSSV-injected shrimp) and 24 h after the second one (CW, PBS-injected shrimp infected with WSSV; EW, UV-WSSV-injected shrimp infected with WSSV). (B) Vp28 expression in hemocytes, intestine and gills of shrimp analyzed by RT-PCR. N was negative control (ddH2O). P was positive control (WSSV). (C) Survival rate analysis of shrimp injected with UV-WSSV; controls were injected with an equal volume of sterile PBS. (D) Survival rate of shrimp, which was analyzed using the log-rank (Mantel–Cox) test. Normal shrimp were divided into two groups, and the experimental group was first trained with UV-WSSV, and then live WSSV was injected after 5 days. In case of the control group, an equal volume of sterile PBS was first injected, and then the same amount of WSSV was administered. (E) WSSV replication was analyzed using Vp28 as an indicator in hemocytes of control and UV-WSSV trained shrimp at 12 and 24 h post WSSV infection (the second infection). The shrimp injected with a corresponding amount of PBS in training period and then infected with WSSV were used as controls. (F, G) The expression patterns of Vago-L (F) and Ficolin (G) in hemocytes of shrimp in the UV-WSSV trained immunity model. Student’s t test was used for statistical analysis, and p < 0.05 was considered to demonstrate statistically significant differences. *p < 0.05, **p < 0.01.
Figure 2PCA score plots based on pairwise comparisons between different groups. (A) EU vs. CP, (B) EW vs. CW, (C) CW vs. CP, and (D) EW vs. EU groups.
PCA validation parameters of various pairwise comparison groups.
| Group | R2X | Pre |
|---|---|---|
| EU vs. CP | 0.516 | 3 |
| EW vs. CW | 0.526 | 3 |
| EW vs. EU | 0.522 | 3 |
| CW vs. CP | 0.533 | 3 |
R2X, interpretability of the model (for X variables); Pre, number of principal components.
Figure 3OPLS-DA score plots for pairwise comparisons between UV-WSSV trained immunity and control groups. (A) EU vs. CP, (B) EW vs. CW, (C) CW vs. CP, and (D) EW vs. EU groups.
Figure 4Permutation plots for pairwise comparisons between UV-WSSV trained immunity and control groups. (A) EU vs. CP, (B) EW vs. CW, (C) CW vs. CP, and (D) EW vs. EU groups.
Significantly changed differential metabolites in EU vs. CP groups.
| Categories | Compound | Pathway involved | Fold change | VIP | |
|---|---|---|---|---|---|
| Amino acid | L-Isoleucine | Valine, leucine and isoleucine biosynthesis | 4.714 | 0.00619 | 1.511 |
| L-Homoserine | Glycine, serine and threonine metabolism | 4.427 | 0.0104 | 1.443 | |
| Hypotaurine | Taurine and hypotaurine metabolism | 4.141 | 0.00013 | 1.834 | |
| N-Acetyl-beta-D-glucosamine | Amino sugar and nucleotide sugar metabolism | 2.332 | 0.000919 | 1.704 | |
| L-Threonine | Valine, leucine and isoleucine biosynthesis | 1.873 | 0.0418 | 1.208 | |
| Propylamine | Biosynthetic pathway of polyamines | 1.684 | 0.00146 | 1.664 | |
| Methyltetrahydrophenanthrenone | Amino acid metabolism | 1.39 | 0.0447 | 1.195 | |
| L-Pyroglutamic acid | Glutathione metabolism | 1.252 | 0.000126 | 1.836 | |
| Cadaverine | Protein digestion and absorption | 0.609 | 9.60E-05 | 1.85 | |
| L-Alanyl-L-alanine | Synthesis of the L-alanyl-L-alanine cross-bridge of peptidoglycan | 0.226 | 0.0111 | 1.433 | |
| L-Citrulline | Arginine biosynthesis | 0.217 | 0.00951 | 1.455 | |
| L-Valine | Valine, leucine and isoleucine biosynthesis | 0.176 | 0.000359 | 1.773 | |
| Urea | Arginine and proline metabolism | 0.082 | 1.09E-06 | 2.003 | |
| L-Ornithine | Arginine biosynthesis | 0.069 | 0.00023 | 1.801 | |
| L-Serine | Protein digestion and absorption | 0.059 | 0.00348 | 1.578 | |
| L-Leucine | Valine, leucine and isoleucine biosynthesis | 0.041 | 0.0209 | 1.335 | |
| L-Proline | Protein digestion and absorption | 0.031 | 3.05E-06 | 1.978 | |
| Taurine | Taurine and hypotaurine metabolism | 0.02 | 0.00184 | 1.643 | |
| L-Aspartic acid | Protein digestion and absorption | 0.019 | 0.00127 | 1.676 | |
| Carbohydrate | D-Sorbitol | Galactose metabolism | 1.551 | 0.0135 | 1.405 |
| D-Glucose-1-phosphate | Glucagon signaling pathway | 1.511 | 0.00311 | 1.59 | |
| 2-O-(alpha-D-Mannosyl)-D-glycerate | Fructose and mannose metabolism | 1.443 | 0.00521 | 1.532 | |
| Methyl beta-D-galactoside | ABC transporters | 1.318 | 0.0279 | 1.285 | |
| Glycolate | Carbon metabolism | 1.259 | 7.36E-06 | 1.953 | |
| N-Acetyl-D-mannosamine | Amino sugar and nucleotide sugar metabolism | 1.159 | 0.00492 | 1.539 | |
| alpha-D-Glucose | Glycolysis/Gluconeogenesis | 0.583 | 0.0288 | 1.279 | |
| Energy | Phosphoenolpyruvic acid | Tricarboxylic acid cycle, TCA cycle | 1.63 | 0.021 | 1.335 |
| Malic acid | Central carbon metabolism in cancer | 1.266 | 0.0155 | 1.384 | |
| (1R,2S)-1-Hydroxypropane-1,2,3-tricarboxylate | Tricarboxylic acid cycle, TCA cycle | 0.783 | 0.0403 | 1.216 | |
| Lipid | sn-Glycerol-1-phosphate | Glycerophospholipid metabolism | 1.862 | 0.00543 | 1.527 |
| (9Z)-Octadecenoic acid | Biosynthesis of unsaturated fatty acids | 1.701 | 0.0401 | 1.217 | |
| Docosenoic acid | Biosynthesis of unsaturated fatty acids | 1.7 | 0.0194 | 1.348 | |
| Methanolphosphate | Biosynthesis of terpenoids and steroids | 1.648 | 0.0254 | 1.302 | |
| Arachidonate | Linoleic acid metabolism | 1.623 | 0.0292 | 1.277 | |
| Heptadecanoic acid | Synthesis of ferritin | 1.292 | 0.00952 | 1.455 | |
| 1-Hexadecylglycerol | Absorption of chimyl alcohol | 1.282 | 0.0309 | 1.267 | |
| Dihydroxymalonic acid | Selective catalytic oxidation of glyceric acid | 1.234 | 0.0141 | 1.398 | |
| Linoleate | Linoleic acid metabolism | 1.218 | 0.00564 | 1.523 | |
| Hexadecanoic acid | Biosynthesis of unsaturated fatty acids | 1.064 | 0.00581 | 1.519 | |
| Squalene | Biosynthesis of alkaloids derived from terpenoid and polyketide | 0.262 | 8.54E-06 | 1.949 | |
| Nucleotide | Uracil | beta-Alanine metabolism | 0.125 | 0.00106 | 1.692 |
| Hypoxanthine | Purine metabolism | 0.09 | 0.000198 | 1.811 | |
| Vitamin | 4-Hydroxypyridine | 4-hydroxypyridine catabolism | 0.942 | 0.0316 | 1.263 |
| Xenobiotics | Biphenyl | Degradation of biphenyl and polychlorinated biphenyl | 0.918 | 0.0275 | 1.288 |
| Naphthalene | Naphthalene family | 0.598 | 0.0167 | 1.372 |
Significantly changed differential metabolites in EW vs. EU groups.
| Categories | Compound | Pathway involved | Fold Change | VIP | |
|---|---|---|---|---|---|
| Carbonic acid derivative | Urea | Arginine and proline metabolism | 2.045 | 0.00139 | 2.094 |
| Amino acid | Maleimide | Anabolism of alkaloids | 1.427 | 0.0444 | 1.501 |
| Glycylglycine | Metabolic absorption of protein | 1.286 | 0.00065 | 2.172 | |
| Cadaverine | Lysine degradation | 1.241 | 0.0134 | 1.763 | |
| Propylamine | biosynthetic pathway of polyamines | 1.139 | 0.0434 | 1.507 | |
| L-Histidine | Biosynthesis of amino acids | 0.756 | 0.0295 | 1.6 | |
| L-Tyrosine | Biosynthesis of amino acids | 0.653 | 0.0281 | 1.611 | |
| L-Alanine | Biosynthesis of amino acids | 0.578 | 0.0128 | 1.773 | |
| Carbohydrate | D-Glucose-1-phosphate | Glycolysis/Gluconeogenesis | 0.759 | 0.0468 | 1.487 |
| beta-D-Glucose | Glycolysis/Gluconeogenesis | 0.66 | 0.0467 | 1.488 | |
| beta-D-Glucose-6-phosphate | Glycolysis/Gluconeogenesis | 0.552 | 0.00359 | 1.976 | |
| beta-D-Fructose-6-phosphate | Glycolysis/Gluconeogenesis | 0.521 | 0.00445 | 1.946 | |
| D-Fructose-6-Phosphate | Glucagon signaling pathway | 0.517 | 9.86E-05 | 2.32 | |
| L-Iditol | L-Iditol production from L-sorbose | 0.434 | 0.00684 | 1.88 | |
| Carboxylic acid | Quinic acid | Phenylalanine, tyrosine and tryptophan biosynthesis | 5.832 | 0.044 | 1.503 |
| Energy | Succinate | Citrate cycle (TCA cycle) | 1.427 | 0.000243 | 2.256 |
| Fumaric acid | Citrate cycle (TCA cycle) | 1.332 | 0.00123 | 2.107 | |
| (1R,2S)-1-Hydroxypropane-1,2,3-tricarboxylate | Tricarboxylic acid cycle | 1.32 | 0.00968 | 1.823 | |
| D-Ribose | Pentose phosphate pathway | 0.667 | 0.0232 | 1.653 | |
| Lipid | 1-Octanol | Microbial production of 1-octanol | 1.132 | 0.0283 | 1.61 |
| Cholesterol | Cholesterol metabolism | 0.555 | 0.0475 | 1.484 | |
| Nucleotide | Uridine | Pyrimidine metabolism | 0.517 | 0.00198 | 2.052 |
| Vitamin | 3-Hydroxypyridine | Photooxidative stress | 1.079 | 0.0223 | 1.662 |
Figure 5Heatmaps plotted using significantly changed metabolites. Each metabolite is represented by a row of colored boxes. Columns represent samples, and rows represent metabolites. Red indicates an increase in the relative level of metabolites, while blue indicates a decrease. (A) Heatmap of EU vs. CP and (B) EW vs. EU groups. A = CP, B = EU, and D = EW.
Figure 6Venn diagram showing common and unique metabolites (EW vs. EU and CW vs. CP groups). There are 16 and 37 unique differential metabolites in EW vs. EU and CW vs. CP groups, respectively. Seven differential metabolites were common between them.
Differential metabolites in the Venn diagram of EW vs. EU and CW vs. CP groups.
| Compound | CW vs. CP | EW vs. EU |
|---|---|---|
| 2,6-ditert-butylphenol | Y | N |
| Squalene | Y | N |
| L-Proline | Y | N |
| Hypotaurine | Y | N |
| 1,5-Anhydro-D-glucitol | Y | N |
| N-Acetyl-D-mannosamine | Y | N |
| Linoleate | Y | N |
| Hexadecanoic acid | Y | N |
| L-Valine | Y | N |
| N-Acetyl-beta-D-glucosamine | Y | N |
| L-Ornithine | Y | N |
| Hypoxanthine | Y | N |
| L-Pyroglutamic acid | Y | N |
| Heptanoic acid | Y | N |
| L-Threonine | Y | N |
| L-Aspartic acid | Y | N |
| Taurine | Y | N |
| Uracil | Y | N |
| 6-Aminohexanoate | Y | N |
| L-Serine | Y | N |
| Cellobiose | Y | N |
| Phosphoenolpyruvic acid | Y | N |
| 1-Hexadecylglycerol | Y | N |
| L-Alanyl-L-alanine | Y | N |
| L-Citrulline | Y | N |
| Sucrose | Y | N |
| 11-Eicosenoic acid | Y | N |
| 2-O-(alpha-D-Mannosyl)-D-glycerate | Y | N |
| Malic acid | Y | N |
| Naphthalene | Y | N |
| Uridine-5-diphospho-N-acetylglucosamine | Y | N |
| L-Leucine | Y | N |
| Ribitol | Y | N |
| N-Acetylserotonin | Y | N |
| Heptadecanoic acid | Y | N |
| Guanosine | Y | N |
| Nonanoic acid | Y | N |
| D-Fructose-6-Phosphate | N | Y |
| Glycylglycine | N | Y |
| Uridine | N | Y |
| beta-D-Glucose-6-phosphate | N | Y |
| beta-D-Fructose-6-phosphate | N | Y |
| L-Iditol | N | Y |
| (1R,2S)-1-Hydroxypropane-1,2,3-tricarboxylate | N | Y |
| L-Alanine | N | Y |
| D-Ribose | N | Y |
| L-Tyrosine | N | Y |
| 1-Octanol | N | Y |
| L-Histidine | N | Y |
| Quinic acid | N | Y |
| Maleimide | N | Y |
| beta-D-Glucose | N | Y |
| Cholesterol | N | Y |
| Fumaric acid | Y | Y |
| Urea | Y | Y |
| 3-Hydroxypyridine | Y | Y |
| Propylamine | Y | Y |
| Cadaverine | Y | Y |
| Succinate | Y | Y |
| D-Glucose-1-phosphate | Y | Y |
Y, DM present; N, DM absent.
Figure 7Enrichment of differential metabolites in distinct KEGG pathways. (A) CP vs. CW and (B) EU vs. EW groups.
Figure 8H3K4me1 and H3K4me3 were involved in trained immunity in shrimp. Histones were extracted from PBS and UV-WSSV trained shrimp at different time points, and H3K4me1 and H3K4me3 were analyzed using western blotting. (A) H3K4me1 modification analyzed by western blotting using anti-H3K4me1 as the primary antibody and statistical analysis based on three experiments. (B) H3K4me3 modification analysis using anti-H3K4me3 as the primary antibody and statistical analysis based on three experiments. The bands of western blotting were digitalized using Image J software, and the differences between trained and control groups at different time points was analyzed by student’s t test, p < 0.05 was accepted as significant difference.